Johnson and Johnson stocks fall after asbestos found in products

The multinational company's stocks tumble after asbestos is found in its popular product.

Johnson and Johnson product
Source: Bloomberg

Johnson and Johnson stock has fallen to its lowest point in 15 years after a bombshell report that the company knew for decades that their products contained asbestos. The multinational business has denied the claim since the report was released.

‘Any suggestion that Johnson and Johnson knew or hid information about the safety of talc is false,’ said the company.

How baby powder turned lethal

Customers have been using Johnson and Johnson baby powder on their skin for decades. However, the talc that the powder is made of is composed of asbestos, a mineral that’s a known carcinogen. The company knew that some of the products contained the cancer-causing material, but insisted it was a small amount that wasn’t harmful to consumers. However, there were internal reports dating as far back as the 1970s that noted that the corporation knew that a large amount of asbestos was found in the talc, but hid that information from the US Food and Drug Administration (FDA).

Reuters reporter, Lisa Girion, noted that Johnson and Johnson appeared to care more about covering up the asbestos finding than warning the public.

‘Company executives, mine managers, scientists, doctors, and lawyers fretted over the problem and how to address it while failing to disclose it to regulators or the public,’ wrote Girion.

There have been thousands of lawsuits against Johnson and Johnson brought by women claiming that the powder caused them to contract ovarian cancer. The company denied the allegation that the product contained any lethal materials and there hasn’t been any conclusive proof that using baby powder leads to getting cancer. Despite the denial, the corporation settled a lawsuit with 22 women and paid $4.7 billion.

What's next for Johnson and Johnson

The corporation has to do serious damage control in the media in order to overcome this latest crisis. It remains to be seen if Johnson and Johnson can survive the damaging report to prove to customers and investors that it didn’t knowingly put lives at risk.

IGA, may distribute information/research produced by its respective foreign marketing partners within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

This information/research prepared by IGA or IG Group is intended for general circulation. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should take into account your specific investment objectives, financial situation or particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. In addition to the disclaimer above, the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

See important Research Disclaimer.

Find articles by writer